Shopping Cart

Your shopping cart is currently empty

Cysteamine hydrochloride

Name: Cysteamine hydrochloride
Brand: TargetMol
SKU: T6460
Price: 29 USD
Availability: InStock
Rating: 5 (10 reviews)

Copy Product Info

😃Good

Catalog No. T6460Cas No. 156-57-0

Alias β-Mercaptoethylamine Hydrochloride, Thioethanolamine Hydrochloride, Cysteamine HCl, Bekaptan, 2-Mercaptoethylamine Hydrochloride, 2-Aminoethanethiol Hydrochloride

Cysteamine hydrochloride is an orally administered small-molecule drug commonly used for the treatment of nephropathic cystinosis. It also functions as an antioxidant and is used in experimental studies to induce gastrointestinal disorders, duodenal ulcers, and kidney injury models in mice.

Cysteamine hydrochloride

Copy Product Info

😃Good

Purity: 99.87%

Catalog No. T6460Alias β-Mercaptoethylamine Hydrochloride, Thioethanolamine Hydrochloride, Cysteamine HCl, Bekaptan, 2-Mercaptoethylamine Hydrochloride, 2-Aminoethanethiol HydrochlorideCas No. 156-57-0

Pack Size	Price	USA Warehouse	Global Warehouse	Quantity
5 g	$29	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.87%

Appearance:Solid

Color:White

Resource Download

COA HNMR LCMS

Product Introduction

Bioactivity

Description	Cysteamine hydrochloride is an orally administered small-molecule drug commonly used for the treatment of nephropathic cystinosis. It also functions as an antioxidant and is used in experimental studies to induce gastrointestinal disorders, duodenal ulcers, and kidney injury models in mice.
In vitro	Cysteamine enhances intracellular glutathione (GSH) levels in cystinotic cells, effectively restoring their altered redox state and demonstrating antioxidant capabilities by increasing glutathione production, thus scavenging harmful OH and HOCl. It also mitigates increased apoptosis rates in cystinotic cells by counteracting the effects of elevated caspase 3 and protein kinase Cε activity. Furthermore, Cysteamine boosts the production of various heat shock proteins (HSP), notably murine Hsp40. It exhibits a dose-dependent mitigation of doxorubicin-induced death in cancer cells, including HeLa and B16 cells, without affecting cell survival on its own. Remarkably, it enhances the efficacy of doxorubicin in doxorubicin-resistant breast cancer cells, significantly increasing cell death. Additionally, Cysteamine (100 μM) not only heightens intracellular GSH levels but also improves the development of matured oocytes to the blastocyst stage in embryo cultures. [1][2]
In vivo	Cysteamine is introduced as a treatment for cystinosis by depleting lysosomal cystine. Cystamine can inhibit transglutaminase activity by binding to the cysteine in its active center. Cysteamine increases brain levels of brain-derived neurotrophic factor (BDNF), which is caused by the increased expression of the heat shock DNAJ-containing protein 1 (HSJ1). Cysteamine inhibits the formation of gastric and mammary tumors that are induced chemically or after irradiation, respectively. The administration of Cysteamine is also able to inhibit the metastasis of pancreatic cancer in a mouse model by decreasing the expression and activity of metalloproteinases. [1]
Synonyms	β-Mercaptoethylamine Hydrochloride, Thioethanolamine Hydrochloride, Cysteamine HCl, Bekaptan, 2-Mercaptoethylamine Hydrochloride, 2-Aminoethanethiol Hydrochloride

Chemical Properties

Molecular Weight	113.61
Formula	C₂H₇NS·HCl
Cas No.	156-57-0
Smiles	Cl.NCCS
Relative Density.	0.75

Storage & Solubility Information

Storage

store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

Ethanol: 22 mg/mL (193.64 mM), Sonication is recommended.

H2O: 21 mg/mL (184.84 mM), Sonication is recommended.

DMSO: 71.43 mg/mL (628.73 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (17.6 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

H2O/Ethanol/DMSO

	1mg	5mg	10mg	50mg
1 mM	8.8020 mL	44.0102 mL	88.0204 mL	440.1021 mL
5 mM	1.7604 mL	8.8020 mL	17.6041 mL	88.0204 mL
10 mM	0.8802 mL	4.4010 mL	8.8020 mL	44.0102 mL
20 mM	0.4401 mL	2.2005 mL	4.4010 mL	22.0051 mL
50 mM	0.1760 mL	0.8802 mL	1.7604 mL	8.8020 mL
100 mM	0.0880 mL	0.4401 mL	0.8802 mL	4.4010 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc